This difference might have significant influence while assessing the stage of HPτ pathology in Primary Age Related Tauopathy and AD while following the current recommendations (Braak et al. 2006; Montine et al. 2012; Crary et al. 2014). This evidence concerns the gene MRS2 and Alzheimer disease.